AACR Announces AACR-Johnson & Johnson Lung Cancer Innovation Science Grants
The American Association for Cancer Research (AACR) has announced the launch of the AACR–Johnson & Johnson Lung Cancer Innovation Science Grants to stimulate research aimed at eradicating this malignancy. This new funding opportunity, which is supported by the Johnson & Johnson Lung Cancer Initiative, is intended to ignite scientific innovation and transformational advances against lung cancer.
A total of $4.5 million will be made available in research funding in support of meritorious research projects. Three multi-institutional research teams that seek novel approaches to the prevention, interception, and cure of lung cancer will each be awarded up to $1.5 million over a period of 3 years. The deadline for submission is Friday, March 2, at 1:00 PM Eastern Standard Time. Research projects will begin on July 1, 2018.
“Lung cancer is the leading cause of cancer death worldwide, and more research is urgently needed if we are to markedly reduce incidence and mortality from this complex disease. These grants will identify innovative strategies to eliminate behaviors that increase lung cancer risk, devise new ways to intercept a lung cancer–causing process before lung cancer occurs, and develop effective treatments that offer the potential for a cure,” said Margaret Foti, PhD, MD (hc), Chief Executive Officer of the AACR.
Proposals submitted for this important funding opportunity should consider the concepts that lung cancer is often caused by behaviors leading to chronic exposure to respiratory carcinogens, which produce cellular/genomic damage; chronic inflammation; alterations in innate and adaptive immunity; and changes in the pulmonary microbiome. Consequently, these events may trigger the escape of transformed cells from immune surveillance. Proposals that characterize premalignant lesions or that substantially improve the detection of lung cancer at more curable stages will also be prioritized for funding.
Grant applications will be accepted from multi-institutional teams, composed of principal investigators from at least two, but no more than three, different institutions. The recipients will formally accept the grants at the AACR Annual Meeting 2018, to be held April 14–18 in Chicago.
Applications must be submitted by 1:00 PM Eastern Standard Time on March 2, 2018, using the proposalCENTRAL website. Further details are available online.
Additional inquiries may be directed to the AACR’s Scientific Review and Grants Administration department at grants@aacr.org.
The content in this post has not been reviewed by the American Society of Clinical Oncology, Inc. (ASCO®) and does not necessarily reflect the ideas and opinions of ASCO®.
